https://pharmabr.news/ 2026-04-02T17:42:56+00:00 https://pharmabr.news/2026/04/02/brazil-to-test-lung-cancer-screening-program-in-public-health-system/ 2026-04-02T17:42:56+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2026/03/21/brazils-anvisa-updates-status-of-semaglutide-registration-requests/ 2026-03-22T13:53:08+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/10/pharmaceutical-companies-wait-up-to-six-years-in-brazil-for-patent-grants-at-inpi-audit-finds/ 2026-03-22T13:52:47+00:00 https://pharmabr.news/wp-content/uploads/2025/08/inpifachada.jpg https://pharmabr.news/2026/03/18/brazils-senate-committee-advances-bill-to-speed-up-patent-examination/ 2026-03-21T20:40:52+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2026/03/17/brazils-inpi-president-blames-users-for-patent-delays/ 2026-03-21T20:34:48+00:00 https://pharmabr.news/wp-content/uploads/2025/08/inpifachada.jpg https://pharmabr.news/2026/03/24/brazil-seen-as-priority-market-for-novo-nordisks-oral-wegovy/ 2026-03-24T12:00:00+00:00 https://pharmabr.news/wp-content/uploads/2025/11/wegovy-2086834.jpg https://pharmabr.news/2026/03/23/brazils-cmed-fines-drug-distributors-and-defends-stricter-regulation/ 2026-03-23T12:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2026/03/22/brazils-hemobras-expands-investments-to-strengthen-domestic-production-of-hemoderivatives/ 2026-03-22T12:00:00+00:00 https://pharmabr.news/wp-content/uploads/2026/03/hemobrs-768x509-1.jpg https://pharmabr.news/2026/03/21/brazils-cmed-debates-new-pricing-models-for-advanced-therapies/ 2026-03-21T12:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/imunoterapia.jpg https://pharmabr.news/2026/03/20/brazils-health-sector-raises-concerns-over-single-hta-agency-bill/ 2026-03-21T03:24:07+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2026/03/19/brazils-palliative-care-services-expand-but-gaps-in-quality-persist/ 2026-03-20T18:38:25+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2026/03/18/brazils-health-insurers-post-record-profits-but-smaller-operators-struggle/ 2026-03-20T18:34:46+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2026/03/17/brazils-anvisa-expands-backlog-reduction-project-for-biologics/ 2026-03-20T17:54:33+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2026/03/16/brazils-ozempic-generics-expected-to-move-billions-in-2026/ 2026-03-20T17:20:21+00:00 https://pharmabr.news/wp-content/uploads/2025/10/shutterstock_2392173591-1920x1080-1.jpg https://pharmabr.news/2026/03/15/brazils-anvisa-details-challenges-for-ai-implementation/ 2026-03-20T16:00:13+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2026/03/09/brazil-health-minister-defends-domestic-production-of-obesity-drugs-to-reduce-prices/ 2026-03-09T20:13:09+00:00 https://pharmabr.news/wp-content/uploads/2025/08/54721018794_6ce3937240_c.jpg https://pharmabr.news/2026/03/08/anvisa-reports-progress-in-plan-to-reduce-regulatory-backlogs-in-brazil/ 2026-03-08T15:46:06+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2026/03/07/brazil-regulator-considers-pilot-program-to-accelerate-review-of-synthetic-medicines/ 2026-03-08T15:39:36+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2026/03/07/brazil-dengue-vaccine-shows-five-year-protection-in-new-study/ 2026-03-07T18:36:51+00:00 https://pharmabr.news/wp-content/uploads/2026/01/butantan-divulgacao5.webp https://pharmabr.news/2026/03/09/brazil-study-highlights-policy-gap-in-menopause-care-and-disproportionate-impact-on-black-women/ 2026-03-09T12:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/07/outubro-rosa-980x653-1.jpg https://pharmabr.news/2026/03/06/brazil-approves-new-hemophilia-drug-to-reduce-bleeding-episodes/ 2026-03-07T00:30:53+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2026/03/05/brazil-advances-law-allowing-drugstores-inside-supermarkets/ 2026-03-06T23:54:58+00:00 https://pharmabr.news/wp-content/uploads/2024/06/medicamento-off-label.jpeg https://pharmabr.news/2026/03/05/brazil-clinical-trials-law-faces-challenge-in-supreme-court/ 2026-03-06T23:43:09+00:00 https://pharmabr.news/wp-content/uploads/2024/06/imunoterapia.jpg https://pharmabr.news/2026/02/26/brazil-industry-denounces-illegal-paraguayan-weight-loss-pens-sold-on-marketplaces/ 2026-03-01T15:29:18+00:00 https://pharmabr.news/wp-content/uploads/2025/10/shutterstock_2392173591-1920x1080-1.jpg https://pharmabr.news/2026/02/23/brazil-expands-oncology-treatment-options-with-new-cancer-drug-indications-from-anvisa/ 2026-03-01T03:03:12+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2026/02/25/brazil-industry-coalition-mobilizes-around-health-economic-industrial-complex-agenda/ 2026-02-28T20:21:43+00:00 https://pharmabr.news/wp-content/uploads/2024/10/cndi_mcamgo_abr_22012024-9.webp https://pharmabr.news/2026/02/26/brazil-city-launches-tirzepatide-program-for-obesity-through-sus/ 2026-02-28T19:34:08+00:00 https://pharmabr.news/wp-content/uploads/2025/10/mounjaro-1024x683-1.jpg https://pharmabr.news/2026/02/26/brazil-faces-diagnostic-odyssey-and-treatment-gaps-for-rare-diseases/ 2026-02-28T19:13:36+00:00 https://pharmabr.news/wp-content/uploads/2024/06/distrofia-muscular-de-duchenne.webp https://pharmabr.news/2026/02/24/brazils-patent-override-bill-for-mounjaro-faces-procedural-delay-in-house-of-representatives/ 2026-02-28T19:05:28+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2026/02/28/brazil-moves-to-use-technological-procurement-for-medical-devices-vaccines-and-health-supplies/ 2026-02-28T22:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2026/02/27/brazil-expands-rare-disease-strategy-with-high-tech-diagnosis-and-expanded-services/ 2026-02-28T17:39:23+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2026/03/01/brazils-santas-casas-join-forces-to-expand-clinical-research-network/ 2026-03-01T16:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/08/image.png https://pharmabr.news/2026/03/02/brazil-debate-over-polylaminin-highlights-importance-of-control-groups-in-clinical-trials/ 2026-03-02T12:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/08/image.png https://pharmabr.news/2025/12/04/ministry_of_health_clarifies_apac_coverage_for_cyclin_inhibitors_in_brazil/ 2026-02-28T17:07:55+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2026/02/28/brazil-lawmaker-plans-to-advance-patent-override-proposal-to-reduce-mounjaro-prices/ 2026-02-28T17:03:41+00:00 https://pharmabr.news/wp-content/uploads/2025/10/mounjaro-1024x683-1.jpg https://pharmabr.news/2026/02/27/brazil-establishes-first-regulation-for-artificial-intelligence-in-medical-practice/ 2026-02-28T16:57:30+00:00 https://pharmabr.news/wp-content/uploads/2025/12/telehealth-on-line-doctor-patient.png https://pharmabr.news/2026/01/13/brazils-butantan-focuses-on-new-vaccine-development-director-says/ 2026-01-17T18:35:36+00:00 https://pharmabr.news/wp-content/uploads/2026/01/butantan-divulgacao5.webp https://pharmabr.news/2026/01/10/brazils-health-regulator-targets-backlog-reduction-and-national-innovation-priority/ 2026-01-17T18:27:33+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2026/01/11/brazil-braces-for-generic-weight-loss-pens-as-ozempic-patent-expires/ 2026-01-17T18:23:03+00:00 https://pharmabr.news/wp-content/uploads/2025/10/shutterstock_2392173591-1920x1080-1.jpg https://pharmabr.news/2025/12/29/over-6-million-brazilians-need-bariatric-surgery-amid-public-system-backlog/ 2025-12-29T20:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/12/28/brazils-anvisa-publishes-qa-document-on-rdc-945-2024/ 2025-12-28T20:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/27/new-regulatory-framework-may-boost-brazils-herbal-medicines-sector/ 2025-12-27T22:29:45+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/23/brazils-anvisa-appoints-substitute-director-to-fourth-directorate/ 2025-12-27T22:13:11+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/26/brazils-cmed-publishes-updated-pricing-rules-for-medicines/ 2025-12-27T18:52:16+00:00 https://pharmabr.news/wp-content/uploads/2024/06/medicamento-off-label.jpeg https://pharmabr.news/2025/12/15/brazil-launches-new-open-data-portal-for-health-and-receives-national-recognition-for-transparency-plan/ 2025-12-15T14:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/15/brazil-to-train-sus-professionals-in-palliative-care-to-expand-end-of-life-support/ 2025-12-15T20:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/08/brazil-strengthens-national-cardiovascular-care-policy-to-reduce-mortality-and-expand-prevention-efforts/ 2025-12-14T18:23:47+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/12/conitec-holds-first-meetings-with-direct-participation-of-civil-society-representatives/ 2025-12-14T18:19:54+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/12/brazil-modernizes-conitec-evaluation-process-and-strengthens-social-participation/ 2025-12-14T18:17:01+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/12/conitecs-rotating-chair-model-draws-criticism-over-continuity-and-governance-in-health-technology-decisions/ 2025-12-14T17:14:38+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/10/ans-incorporates-new-treatment-for-ulcerative-colitis-into-mandatory-coverage-list/ 2025-12-14T17:13:45+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/12/14/stagnation-of-medical-residency-programs-fuels-growth-of-non-accredited-specializations-in-brazil/ 2025-12-14T17:08:29+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/12/10/cioms-releases-new-guideline-on-the-use-of-artificial-intelligence-in-pharmacovigilance/ 2025-12-14T17:02:31+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/12/anvisa-suspends-revision-process-of-rdc-327-on-medical-cannabis-regulation/ 2025-12-14T16:58:33+00:00 https://pharmabr.news/wp-content/uploads/2025/10/pesquisa_canabidioldentro.jpg https://pharmabr.news/2025/12/13/expansion-of-medical-school-programs-through-court-injunctions-advances-in-brazilian-cities-lacking-basic-infrastructure/ 2025-12-14T16:32:50+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/12/15/senate-president-davi-alcolumbre-promises-to-direct-parliamentary-amendments-to-anvisa-and-ans/ 2025-12-15T16:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/12/13/medical-societies-in-brazil-issue-new-warning-against-testosterone-use-in-women/ 2025-12-14T15:18:14+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/12/10/stj-postpones-ruling-on-semaglutide-patent-dispute-delaying-entry-of-ozempic-generics-in-brazil/ 2025-12-14T15:15:03+00:00 https://pharmabr.news/wp-content/uploads/2025/10/shutterstock_2392173591-1920x1080-1.jpg https://pharmabr.news/2025/12/10/brazil-announces-r18-4-billion-investment-to-expand-national-health-infrastructure/ 2025-12-14T15:10:56+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/11/expansion-of-mammography-access-in-brazils-sus-faces-geographic-and-service-delivery-challenges/ 2025-12-14T14:03:13+00:00 https://pharmabr.news/wp-content/uploads/2024/07/outubro-rosa-980x653-1.jpg https://pharmabr.news/2025/12/12/brazils-anvisa-publishes-new-guideline-on-qualification-of-impurities-and-degradation-products-in-medicines/ 2025-12-14T13:59:59+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/15/family-physicians-reduce-avoidable-hospitalizations-and-costs-for-brazils-public-health-system-study-shows/ 2025-12-15T10:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/11/18/special-report-inside-the-decision-that-reshapes-brazils-anvisa-drug-review-process-2/ 2025-12-14T13:52:03+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/14/brazilian-senate-approves-measures-to-strengthen-protections-for-people-with-type-1-diabetes/ 2025-12-14T13:41:55+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/12/11/health-sector-receives-largest-share-of-parliamentary-amendments-in-brazils-2026-federal-budget/ 2025-12-14T13:39:02+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/12/10/brazil-signs-health-technology-cooperation-agreement-with-the-united-kingdom/ 2025-12-14T13:34:34+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/11/sao-paulo-records-197000-physicians-in-2025-a-66-increase-over-a-decade/ 2025-12-14T01:13:24+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/12/12/anvisa-approves-requirements-for-electronic-prescriptions-of-controlled-substances/ 2025-12-14T01:00:56+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/13/anvisa-leads-approval-of-guiding-document-for-development-of-ich-m18-guideline/ 2025-12-14T00:56:09+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/14/ans-highlights-regulatory-agenda-development-during-meeting-of-the-supplementary-health-chamber-camss/ 2025-12-14T16:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/12/14/anvisa-approves-2026-2027-regulatory-agenda-with-155-strategic-topics/ 2025-12-14T20:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/12/health-insurers-profits-surge-140-in-brazils-third-quarter-amid-financial-gains/ 2025-12-14T00:30:21+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/12/11/takeda-says-there-will-be-no-restriction-in-dengue-vaccine-supply-in-brazil-in-2026/ 2025-12-14T00:26:08+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/12/11/anvisa-updates-priority-categories-for-drug-registration-to-modernize-regulatory-framework/ 2025-12-14T00:22:45+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/11/wave-of-patent-expirations-for-biologic-drugs-reshapes-brazils-pharmaceutical-market/ 2025-12-14T00:18:59+00:00 https://pharmabr.news/wp-content/uploads/2024/10/cndi_mcamgo_abr_22012024-9.webp https://pharmabr.news/2025/12/11/new-survey-maps-brazils-clinical-research-landscape-and-highlights-regional-disparities/ 2025-12-14T00:16:15+00:00 https://pharmabr.news/wp-content/uploads/2024/08/image.png https://pharmabr.news/2025/12/09/brazil-launches-orion-public-health-research-complex-to-strengthen-infectious-disease-capacity/ 2025-12-13T23:01:39+00:00 https://pharmabr.news/wp-content/uploads/2024/08/image.png https://pharmabr.news/2025/12/09/ans-adds-robotic-prostate-cancer-surgery-to-mandatory-health-plan-coverage-in-brazil/ 2025-12-12T23:06:08+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/12/09/average-increase-for-collective-health-plans-in-brazil-reaches-11-15-in-2025-ans-data-show/ 2025-12-12T23:00:29+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/12/09/dependence-on-parliamentary-amendments-challenges-planning-and-equity-in-brazils-public-health-system/ 2025-12-12T16:24:58+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/12/09/patent-delay-of-vonau-flash-highlights-innovation-bottleneck-in-brazil/ 2025-12-12T14:39:12+00:00 https://pharmabr.news/wp-content/uploads/2025/08/inpifachada.jpg https://pharmabr.news/2025/12/09/brazilian-car-t-therapy-achieves-complete-remission-in-72-of-patients-in-early-study/ 2025-12-12T12:30:13+00:00 https://pharmabr.news/wp-content/uploads/2024/08/image.png https://pharmabr.news/2025/12/09/brazil-could-see-up-to-1-2-million-lawsuits-per-year-against-health-insurers-study-finds/ 2025-12-11T22:21:10+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/12/08/brazil-accelerates-review-of-20-weight-loss-injection-pens-at-the-ministry-of-healths-request/ 2025-12-11T22:07:31+00:00 https://pharmabr.news/wp-content/uploads/2025/11/wegovy-2086834.jpg https://pharmabr.news/2025/12/08/brazils-pharmacy-retail-sector-grows-above-10-as-regional-expansion-accelerates/ 2025-12-08T16:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/medicamento-off-label.jpeg https://pharmabr.news/2025/12/06/civil-society-urges-stronger-oversight-of-abusive-practices-by-health-plans-in-brazil/ 2025-12-07T18:42:26+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/12/05/brazilian-experts-highlight-prioritization-and-data-integration-as-key-challenges-for-expanding-health-care-access/ 2025-12-07T18:33:47+00:00 https://pharmabr.news/wp-content/uploads/2024/06/budget_2022_health_istock_660x330.jpg https://pharmabr.news/2025/12/03/federal-government-enacts-tax-exemption-for-medicine-donations-in-brazil/ 2025-12-07T18:26:11+00:00 https://pharmabr.news/wp-content/uploads/2024/06/medicamento-off-label.jpeg https://pharmabr.news/2025/12/04/senate-committee-approves-mandatory-proficiency-exam-for-new-physicians-in-brazil/ 2025-12-07T18:19:42+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/12/05/ministry-of-health-appoints-meiruze-sousa-freitas-to-lead-new-brazilian-ethics-in-research-body-inaep/ 2025-12-07T18:03:20+00:00 https://pharmabr.news/wp-content/uploads/2024/08/image.png https://pharmabr.news/2025/12/08/congress-advances-proposal-to-expand-rights-for-people-with-type-1-diabetes-in-brazil/ 2025-12-08T10:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/12/07/brazil-study-reveals-barriers-to-hemophilia-treatment-adherence/ 2025-12-07T17:03:23+00:00 https://pharmabr.news/wp-content/uploads/2024/06/clinical-trials-400x200-1.jpg https://pharmabr.news/2025/12/07/brazil-expands-technical-training-program-to-strengthen-sus-workforce/ 2025-12-07T16:51:42+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/05/brazils-supreme-court-tightens-criteria-for-coverage-of-treatments-outside-ans-list/ 2025-12-07T16:47:46+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/12/06/brazilian-public-hearing-urges-enforcement-of-the-60-day-law-to-reduce-skin-cancer-mortality/ 2025-12-07T16:34:09+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/12/05/brazilian-public-hearing-highlights-role-of-taxation-and-limited-specialist-access-in-worsening-skin-cancer-outcomes/ 2025-12-07T16:19:55+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/12/05/brazil-publishes-list-of-withdrawn-and-substituted-applications-under-rdc-997-2025/ 2025-12-07T15:02:32+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/12/04/brazil-advances-discussions-to-modernize-national-health-plan-legislation/ 2025-12-07T14:56:47+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/12/04/brazilian-court-upholds-ans-rule-requiring-hta-review-for-advanced-therapies/ 2025-12-07T14:48:01+00:00 https://pharmabr.news/wp-content/uploads/2025/08/bancoimagemsco_ap_363858.jpg https://pharmabr.news/2025/12/03/brazil-to-launch-national-medication-platform-to-strengthen-judicial-and-administrative-decision-making/ 2025-12-07T14:37:41+00:00 https://pharmabr.news/wp-content/uploads/2025/08/bancoimagemsco_ap_363858.jpg https://pharmabr.news/2025/12/03/public-hearing-in-brazilian-house-of-representatives-highlights-rising-fiscal-impact-of-health-judicialization/ 2025-12-07T14:33:36+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/12/03/brazils-collective-health-plans-show-higher-average-premium-increases-than-individual-contracts/ 2025-12-07T14:26:32+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/12/03/teleconsultations-surge-as-a-consolidated-modality-in-brazils-health-system/ 2025-12-07T14:13:31+00:00 https://pharmabr.news/wp-content/uploads/2025/12/16348062576_e1fdb7ef24_5k.webp https://pharmabr.news/2025/12/02/brazils-audit-court-upholds-legality-of-atesta-cfm-platform-and-antitrust-authority-closes-inquiry/ 2025-12-05T02:57:15+00:00 https://pharmabr.news/wp-content/uploads/2025/12/16348062576_e1fdb7ef24_5k.webp https://pharmabr.news/2025/12/02/brazil-study-highlights-scale-and-profile-of-schizophrenia-in-the-adult-population/ 2025-12-04T23:47:41+00:00 https://pharmabr.news/wp-content/uploads/2024/06/clinical-trials-400x200-1.jpg https://pharmabr.news/2025/12/02/brazilian-drugstores-consider-adopting-south-korean-experiential-retail-model/ 2025-12-04T23:42:40+00:00 https://pharmabr.news/wp-content/uploads/2025/10/farmacia-popular.jpeg https://pharmabr.news/2025/12/02/brazil-launches-national-census-of-oncology-centers-to-strengthen-cancer-care-planning/ 2025-12-04T23:33:57+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/02/brazil-establishes-national-residency-in-health-policy-to-expand-specialist-training-in-the-sus/ 2025-12-04T20:37:36+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/12/02/novo-nordisks-billion-real-investment-positions-brazil-as-hub-for-next-gen-semaglutide-production/ 2025-12-03T12:10:18+00:00 https://pharmabr.news/wp-content/uploads/2025/10/shutterstock_2392173591-1920x1080-1.jpg https://pharmabr.news/2025/12/01/brazilian-medical-entities-call-for-immediate-ban-on-compounded-weight-loss-pens/ 2025-12-03T12:02:06+00:00 https://pharmabr.news/wp-content/uploads/2025/10/shutterstock_2392173591-1920x1080-1.jpg https://pharmabr.news/2025/11/29/health-committee-debates-rise-in-counterfeit-medicines-and-public-health-risks-in-brazil/ 2025-11-30T14:06:09+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/11/30/brazil-approves-new-national-policy-to-strengthen-health-residencies-across-country/ 2025-11-30T14:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/11/30/brazil-faces-rising-costs-for-prostate-cancer-treatment-in-sus/ 2025-11-30T18:00:00+00:00 https://pharmabr.news/wp-content/uploads/2025/10/11.11.2019_novembro_azul.jpg https://pharmabr.news/2025/11/29/brazil-launches-new-therapeutic-consensus-for-leprosy-to-strengthen-treatment-guidelines/ 2025-11-30T03:47:37+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/11/28/brazil-records-low-uptake-of-the-agora-tem-especialistas-program-among-private-health-plans/ 2025-11-30T03:40:33+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/11/30/brazil-opens-national-super-center-to-accelerate-cancer-diagnosis/ 2025-11-30T10:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/12/01/ministry-of-health-details-initiatives-on-cancer-prevention-diagnosis-and-treatment-in-brazil/ 2025-12-01T14:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/28/brazil-establishes-rules-for-sus-linked-projects-to-issue-incentivized-debentures/ 2025-11-29T23:55:34+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/29/brazil-hospital-expands-risk-sharing-agreements-to-broaden-access-to-innovative-cancer-therapies/ 2025-11-29T23:48:48+00:00 https://pharmabr.news/wp-content/uploads/2025/08/create-a-highly-detailed-high-resolution-image-focusing-on-brazils-medical.png https://pharmabr.news/2025/11/28/brazil-federal-police-dismantle-illegal-factory-producing-tirzepatide-slimming-pens/ 2025-11-29T23:41:56+00:00 https://pharmabr.news/wp-content/uploads/2025/10/bd011972-125d-4c2d-8845-de9ac03d4d56.jpeg https://pharmabr.news/2025/12/01/brazils-ministry-of-health-warns-that-medical-school-expansion-must-meet-quality-standards-to-ensure-proper-training-of-doctors/ 2025-12-01T10:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/28/brazil-tcu-identifies-critical-flaws-in-monitoring-of-primary-health-care-construction-projects/ 2025-11-29T23:22:24+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/28/brazil-sees-expanding-arsenal-of-innovations-in-prostate-cancer-care/ 2025-11-29T22:06:05+00:00 https://pharmabr.news/wp-content/uploads/2025/11/img20201104145313985-768x512-1.jpg https://pharmabr.news/2025/11/28/brazil-alarm-over-prostate-cancer-underdiagnosis-as-44-of-men-never-visit-a-urologist/ 2025-11-29T21:25:48+00:00 https://pharmabr.news/wp-content/uploads/2025/10/11.11.2019_novembro_azul.jpg https://pharmabr.news/2025/11/28/brazil-rsv-vaccine-to-arrive-in-sus-in-december-with-1-8-million-doses/ 2025-11-29T21:09:04+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/27/novo-nordisk-seeks-approval-for-higher-dose-wegovy-formulation-in-brazil/ 2025-11-29T20:43:11+00:00 https://pharmabr.news/wp-content/uploads/2025/11/wegovy-2086834.jpg https://pharmabr.news/2025/11/27/brazil-study-reveals-how-some-breast-cancer-tumors-evade-treatment/ 2025-11-29T20:38:33+00:00 https://pharmabr.news/wp-content/uploads/2024/07/outubro-rosa-980x653-1.jpg https://pharmabr.news/2025/11/27/brazil-anvisa-updates-qa-on-rdc-359-2020-to-clarify-api-dossier-requirements/ 2025-11-29T20:19:56+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/27/brazil-ans-updates-rules-for-self-managed-health-plan-operators-to-strengthen-governance-and-oversight/ 2025-11-29T20:13:53+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/11/27/brazil-ans-incorporates-four-new-technologies-into-mandatory-health-plan-coverage/ 2025-11-29T20:09:26+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/11/27/brazils-senate-approves-mammography-for-women-from-40-years-old-under-sus/ 2025-11-29T20:04:36+00:00 https://pharmabr.news/wp-content/uploads/2024/07/outubro-rosa-980x653-1.jpg https://pharmabr.news/2025/11/27/brazil-advances-draft-law-to-regulate-novel-cancer-fighting-technologies-under-sus/ 2025-11-29T19:52:34+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/11/26/brazil-warns-of-persistent-gaps-in-chagas-disease-diagnosis-and-treatment-amid-rise-in-chronic-cases/ 2025-11-29T19:49:59+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/26/brazil-standardizes-laboratory-exam-codes-to-boost-data-interoperability-and-epidemic-response/ 2025-11-29T16:37:46+00:00 https://pharmabr.news/wp-content/uploads/2024/08/image-1.png https://pharmabr.news/2025/11/26/brazil-signs-vaccine-agreement-with-paho-to-secure-updated-immunizations-at-lower-cost/ 2025-11-29T16:37:01+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/26/brazil-warns-rising-zolpidem-misuse-is-turning-into-public-health-problem/ 2025-11-29T16:12:52+00:00 https://pharmabr.news/wp-content/uploads/2025/11/1f01f028dee0fcd4dbafc15db065b362b779bc82.jpeg https://pharmabr.news/2025/11/26/brazils-farmacia-popular-boosts-sales-and-draws-even-premium-pharmacy-chains/ 2025-11-29T14:56:51+00:00 https://pharmabr.news/wp-content/uploads/2025/10/farmacia-popular.jpeg https://pharmabr.news/2025/11/26/brazil-faces-complex-challenge-in-pricing-advanced-therapies-amid-surge-of-innovation/ 2025-11-29T14:51:30+00:00 https://pharmabr.news/wp-content/uploads/2024/06/imunoterapia.jpg https://pharmabr.news/2025/11/26/brazil-braces-for-major-shift-as-stj-considers-patent-term-adjustment-that-could-shake-pharmaceutical-sector/ 2025-11-29T14:32:41+00:00 https://pharmabr.news/wp-content/uploads/2024/06/medicamento-off-label.jpeg https://pharmabr.news/2025/11/25/promising-prostate-cancer-drug-not-yet-available-in-brazils-sus-despite-extended-survival-benefit/ 2025-11-29T14:24:11+00:00 https://pharmabr.news/wp-content/uploads/2025/10/11.11.2019_novembro_azul.jpg https://pharmabr.news/2025/11/25/brazil-considers-ban-on-canceling-elderly-health-plans-amid-ans-proposal/ 2025-11-29T14:17:10+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/11/25/ministry-of-health-highlights-importance-of-clinical-trials-to-expand-access-and-innovation-in-brazil/ 2025-11-29T14:09:36+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/25/brazil-approves-first-in-country-gene-therapy-clinical-trial-for-spinal-muscular-atrophy/ 2025-11-29T13:02:34+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/25/brazils-ans-to-regulate-discount-health-cards-after-stj-decision/ 2025-11-29T02:36:53+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/11/25/brazil-survey-finds-that-over-half-of-adults-have-never-seen-a-dermatologist/ 2025-11-27T17:15:29+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/11/24/brazil-sees-dramatic-expansion-of-parliamentary-amendments-shaping-sus-budget/ 2025-11-27T16:29:56+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/11/25/brazil-loses-r-26-billion-per-year-to-corruption-in-health-says-ies/ 2025-11-27T14:51:53+00:00 https://pharmabr.news/wp-content/uploads/2025/08/create-a-highly-detailed-high-resolution-image-focusing-on-brazils-medical.png https://pharmabr.news/2025/11/25/anvisa-reports-progress-in-modernization-plan-and-reinforces-commitment-to-reducing-regulatory-backlog/ 2025-11-26T22:43:05+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/24/brazil-launches-new-pdps-and-partnerships-to-strengthen-health-industrial-complex/ 2025-11-26T21:55:54+00:00 https://pharmabr.news/wp-content/uploads/2024/10/cndi_mcamgo_abr_22012024-9.webp https://pharmabr.news/2025/11/24/brazils-agricultural-research-agency-gets-cannabis-research-greenlight/ 2025-11-24T10:00:00+00:00 https://pharmabr.news/wp-content/uploads/2025/10/pesquisa_canabidioldentro.jpg https://pharmabr.news/2025/11/21/brazil-strengthens-regulatory-convergence-at-ich-and-iprp-meetings-in-singapore/ 2025-11-22T20:01:09+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/22/anvisa-creates-committee-to-monitor-implementation-of-its-regulatory-backlog-action-plan/ 2025-11-22T19:58:45+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/21/brazil-enables-production-of-biological-dressing-made-from-tilapia-skin/ 2025-11-22T19:53:48+00:00 https://pharmabr.news/wp-content/uploads/2024/06/clinical-trials-400x200-1.jpg https://pharmabr.news/2025/11/23/brazils-anvisa-alerts-on-prohibition-of-unregistered-weight-loss-injection-pens/ 2025-11-23T14:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/21/brazil-seminar-cadifa-2025-gathers-more-than-1000-participants-in-person-and-online/ 2025-11-22T19:33:42+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/21/brazil-study-shows-decline-in-preventive-womens-health-procedures-in-supplementary-health/ 2025-11-22T19:18:34+00:00 https://pharmabr.news/wp-content/uploads/2024/07/outubro-rosa-980x653-1.jpg https://pharmabr.news/2025/11/20/brazil-advances-partnership-to-develop-first-targeted-treatment-for-yellow-fever/ 2025-11-22T13:20:31+00:00 https://pharmabr.news/wp-content/uploads/2024/08/image.png https://pharmabr.news/2025/11/20/stf-suspends-brazils-review-of-advertising-rules-for-medicines-and-foods/ 2025-11-22T13:06:13+00:00 https://pharmabr.news/wp-content/uploads/2025/08/bancoimagemsco_ap_363858.jpg https://pharmabr.news/2025/11/20/brazils-regulator-reclassifies-omeprazole-20-mg-as-over-the-counter-medicine/ 2025-11-22T12:40:42+00:00 https://pharmabr.news/wp-content/uploads/2025/11/omeprazol-20mg-com-56-capsulas-generico-teuto.jpg https://pharmabr.news/2025/11/20/brazilian-research-institutions-advance-plan-to-deliver-car-t-therapy-by-2026/ 2025-11-22T12:29:09+00:00 https://pharmabr.news/wp-content/uploads/2025/11/dsc0608.webp https://pharmabr.news/2025/11/11/special-report-inside-the-decision-that-reshapes-brazils-anvisa-drug-review-process/ 2025-11-22T01:06:02+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/19/brazilian-health-council-urges-parity-and-stronger-social-oversight-in-human-research-regulation/ 2025-11-20T17:56:39+00:00 https://pharmabr.news/wp-content/uploads/2025/11/ab3d47bb-516a-404e-bee5-23da270a7df7.jpeg https://pharmabr.news/2025/11/19/brazilian-states-discuss-oncology-challenges-and-drug-management-gaps/ 2025-11-20T17:51:30+00:00 https://pharmabr.news/wp-content/uploads/2025/11/Foto-1-Foto_Sandro-Araujo_Agencia-Saude-DF.jpg https://pharmabr.news/2025/11/18/brazil-advances-domestic-production-with-2-1-million-units-of-insulin-glargine-delivered-to-sus/ 2025-11-20T02:02:57+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/19/anvisa-launches-new-tool-to-issue-medical-device-certificates-in-brazil/ 2025-11-19T22:53:13+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/19/brazils-health-ministry-launches-four-front-action-against-doctors-profiting-from-anti-vaccine-content/ 2025-11-19T22:21:25+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/11/20/brazil-warns-of-rising-counterfeit-risks-as-high-value-medicines-top-falsification-list/ 2025-11-20T10:00:00+00:00 https://pharmabr.news/wp-content/uploads/2025/10/mounjaro-1024x683-1.jpg https://pharmabr.news/2025/11/22/brazil-sees-more-than-20-rise-in-stroke-cases-among-young-adults-aged-18-45/ 2025-11-22T10:00:00+00:00 https://pharmabr.news/wp-content/uploads/2025/11/pexels-photo-6291261.jpeg https://pharmabr.news/2025/11/19/brazils-largest-pharmaceutical-firm-secures-r-107-6-million-bndes-funding-to-expand-rd-centre/ 2025-11-19T17:40:56+00:00 https://pharmabr.news/wp-content/uploads/2025/11/sededobndes.jpg https://pharmabr.news/2025/11/21/brazil-to-launch-national-platform-for-medication-related-judicial-health-cases/ 2025-11-21T10:00:00+00:00 https://pharmabr.news/wp-content/uploads/2025/08/bancoimagemsco_ap_363858.jpg https://pharmabr.news/2025/11/17/brazil-advances-with-construction-of-first-intelligent-hospital-within-the-sus-health-system/ 2025-11-19T12:23:39+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/18/brazils-drugstore-market-sees-r-13-2-billion-in-sales-driven-by-diabetes-and-obesity-treatments/ 2025-11-19T12:17:01+00:00 https://pharmabr.news/wp-content/uploads/2025/10/shutterstock_2392173591-1920x1080-1.jpg https://pharmabr.news/2025/11/11/supreme-court-in-brazil-sets-1-december-2025-deadline-for-government-action-plan-on-pricing-and-access-to-non-incorporated-medicines/ 2025-11-18T13:43:17+00:00 https://pharmabr.news/wp-content/uploads/2025/08/bancoimagemsco_ap_363858.jpg https://pharmabr.news/2025/11/17/brazils-oncology-society-launches-anti-bias-guide-amid-concerns-over-racial-disparities-in-cancer-diagnosis/ 2025-11-17T18:00:00+00:00 https://pharmabr.news/wp-content/uploads/2025/11/1a39173e65486fab8249fb04458ac834_XL.jpg https://pharmabr.news/2025/11/13/brazil-updates-conitecs-structure-and-decision-making-process-adding-voting-civil-society-representatives/ 2025-11-16T16:12:12+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/16/brazil-highlights-prostate-cancer-awareness-as-congress-building-turns-blue/ 2025-11-17T00:00:00+00:00 https://pharmabr.news/wp-content/uploads/2025/11/img20201104145313985-768x512-1.jpg https://pharmabr.news/2025/11/14/brazil-prepares-new-drug-pricing-rule-expected-in-december/ 2025-11-16T15:44:34+00:00 https://pharmabr.news/wp-content/uploads/2024/06/medicamento-off-label.jpeg https://pharmabr.news/2025/11/16/brazil-secures-us300-million-donation-for-climate-health-plan/ 2025-11-16T14:35:03+00:00 https://pharmabr.news/wp-content/uploads/2025/08/54721018794_6ce3937240_c.jpg https://pharmabr.news/2025/11/14/brazils-drug-evaluation-office-implements-new-procedures-to-comply-with-anvisas-rdc-997-2025/ 2025-11-16T14:28:01+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/13/brazil-advances-bill-removing-requirement-for-gmp-certification-in-country-of-origin/ 2025-11-16T14:17:44+00:00 https://pharmabr.news/wp-content/uploads/2024/08/camara-dos-deputados-orgao-fotografia-610x406-1.jpg https://pharmabr.news/2025/11/15/brazil-performs-pioneering-remote-adjustable-surgery-for-parkinsons-disease/ 2025-11-16T14:16:31+00:00 https://pharmabr.news/wp-content/uploads/2025/10/feeced20-b9c5-11ee-9071-eb4585ca0408.jpg.webp https://pharmabr.news/2025/11/17/brazil-study-finds-obesity-not-significantly-altering-breast-cancer-survival/ 2025-11-17T16:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/07/outubro-rosa-980x653-1.jpg https://pharmabr.news/2025/11/16/brazil-set-to-see-key-anticoagulant-drug-become-much-cheaper-as-patent-expires/ 2025-11-16T14:07:20+00:00 https://pharmabr.news/wp-content/uploads/2025/11/API-CAT.jpeg https://pharmabr.news/2025/11/14/brazil-updates-national-vaccine-cold-chain-manual/ 2025-11-15T22:39:45+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/14/brazils-anvisa-moves-to-cut-review-times-while-interfarma-raises-transparency-concerns/ 2025-11-15T21:36:51+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/13/brazil-signs-law-to-boost-autism-diagnosis-among-adults-and-older-adults/ 2025-11-15T21:27:43+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ministerio-da-saude.jpg https://pharmabr.news/2025/11/14/brazils-anvisa-issues-call-for-scientific-evidence-on-medical-cannabis-cultivation-to-support-future-regulation/ 2025-11-15T21:23:11+00:00 https://pharmabr.news/wp-content/uploads/2025/10/pesquisa_canabidioldentro.jpg https://pharmabr.news/2025/11/15/brazils-ans-stresses-that-human-life-cannot-be-treated-as-a-detail-in-debate-over-high-cost-drugs/ 2025-11-15T22:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/ans-sede-768x389-1.png https://pharmabr.news/2025/11/15/brazils-medical-cannabis-sector-gathers-in-sao-paulo-as-industry-anticipates-federal-regulation/ 2025-11-15T21:10:30+00:00 https://pharmabr.news/wp-content/uploads/2025/10/pesquisa_canabidioldentro.jpg https://pharmabr.news/2025/11/17/brazil-survey-shows-strong-awareness-of-electronic-patient-records-but-persistent-concern-over-data-security/ 2025-11-17T10:00:00+00:00 https://pharmabr.news/wp-content/uploads/2024/06/clinical-trials-400x200-1.jpg https://pharmabr.news/2025/11/14/brazil-sets-reimbursement-value-for-cyclin-inhibitor-therapies-in-the-sus-but-access-concerns-remain/ 2025-11-15T21:01:47+00:00 https://pharmabr.news/wp-content/uploads/2024/07/outubro-rosa-980x653-1.jpg https://pharmabr.news/2025/11/12/brazils-ministry-of-health-allocates-r-65-million-incentive-to-retain-health-professional-residents/ 2025-11-15T20:41:55+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/11/12/brazil-revisits-the-quality-of-medical-education-government-plans-inspections-of-all-medical-schools-in-2026-and-considers-closing-vacancies/ 2025-11-15T20:32:53+00:00 https://pharmabr.news/wp-content/uploads/2024/06/doctor-1228627_1280.jpg https://pharmabr.news/2025/11/13/brazils-anvisa-creates-task-force-to-speed-up-review-of-health-services-architecture-projects-under-pac-saude/ 2025-11-15T16:58:29+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/13/brazils-anvisa-issues-final-call-for-contributions-to-regional-consultation-on-ich-m4qr2-guideline/ 2025-11-15T16:37:11+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/13/brazils-judiciary-releases-new-cnj-guide-to-standardize-rulings-on-access-to-medicines/ 2025-11-15T16:28:11+00:00 https://pharmabr.news/wp-content/uploads/2025/08/bancoimagemsco_ap_363858.jpg https://pharmabr.news/2025/11/13/brazilian-researchers-investigate-unprecedented-method-to-treat-severe-lung-diseases/ 2025-11-15T16:20:25+00:00 https://pharmabr.news/wp-content/uploads/2024/06/imunoterapia.jpg https://pharmabr.news/2025/11/07/brazil-anvisa-announces-new-measures-to-cut-drug-review-times-to-one-year/ 2025-11-15T15:12:37+00:00 https://pharmabr.news/wp-content/uploads/2024/06/anvisa-marcelo-camargo-agencia-brasil.jpg https://pharmabr.news/2025/11/11/brazil-tests-ai-project-to-speed-up-health-related-court-cases-but-expansion-depends-on-stable-funding/ 2025-11-15T15:08:13+00:00 https://pharmabr.news/wp-content/uploads/2024/08/image-1.png https://pharmabr.news/2025/11/12/brazil-approves-new-national-policy-and-awareness-week-for-mens-health/ 2025-11-15T14:51:58+00:00 https://pharmabr.news/wp-content/uploads/2025/10/11.11.2019_novembro_azul.jpg